OBIO · Company research
Orchestra BioMed Holdings, Inc. (OBIO): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Orchestra BioMed (OBIO) Falls 5.05% to $5.45 as Shares Retreat Toward Lower Support - Bull Pennant - https://www.dars.gov.et/ | Orchestra BioMed (OBIO) Falls 5.05% to $5.45 as Shares Retreat Toward Lower Support - Bull Pennant https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 17, 2026 | neutral | 0 | 0.6 |
| Orchestra BioMed Has A Clearer Trial Timeline But A Demanding Valuation - Seeking Alpha | Orchestra BioMed Has A Clearer Trial Timeline But A Demanding Valuation Seeking Alpha | View source ↗ | Seeking Alpha | Oct 15, 2026 | neutral | 0 | 0.6 |
| (OBIO) Risk Channels and Responsive Allocation - Stock Traders Daily | (OBIO) Risk Channels and Responsive Allocation Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 9, 2026 | neutral | 0 | 0.6 |
| A planned 15,000-share sale at Orchestra BioMed (OBIO) averages $6.36 per share. - Stock Titan | A planned 15,000-share sale at Orchestra BioMed (OBIO) averages $6.36 per share. Stock Titan | View source ↗ | Stock Titan | Oct 2, 2026 | neutral | 0 | 0.6 |
| $OBIO stock is down 9% today. Here's what we see in our data. - Quiver Quantitative | $OBIO stock is down 9% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Oct 2, 2026 | neutral | 0 | 0.6 |
| After three 15,000-share sales, Sherman proposes another at Orchestra BioMed (OBIO). - Stock Titan | After three 15,000-share sales, Sherman proposes another at Orchestra BioMed (OBIO). Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| Across 13 countries, Orchestra BioMed (OBIO) exceeds its blood-pressure trial enrollment target. - Stock Titan | Across 13 countries, Orchestra BioMed (OBIO) exceeds its blood-pressure trial enrollment target. Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| A pacemaker therapy trial for hard-to-control blood pressure enrolled 330 people - Stock Titan | A pacemaker therapy trial for hard-to-control blood pressure enrolled 330 people Stock Titan | View source ↗ | Stock Titan | Oct 1, 2026 | neutral | 0 | 0.6 |
| How Orchestra Biomed Holdings Inc Com (OBIO) Affects Rotational Strategy Timing - Stock Traders Daily | How Orchestra Biomed Holdings Inc Com (OBIO) Affects Rotational Strategy Timing Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 28, 2026 | neutral | 0 | 0.6 |
| Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength? - Yahoo Finance | Strength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength? Yahoo Finance | View source ↗ | Yahoo Finance | Sep 21, 2026 | neutral | 0 | 0.6 |
| These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them? - Stocktwits | These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them? Stocktwits | View source ↗ | Stocktwits | Sep 10, 2026 | neutral | 0 | 0.6 |
| Orchestra BioMed (OBIO) CEO buys more of his own stock - Stock Titan | Orchestra BioMed (OBIO) CEO buys more of his own stock Stock Titan | View source ↗ | Stock Titan | Sep 8, 2026 | neutral | 0 | 0.6 |
| $OBIO stock is up 18% today. Here's what we see in our data. - Quiver Quantitative | $OBIO stock is up 18% today. Here's what we see in our data. Quiver Quantitative | View source ↗ | Quiver Quantitative | Aug 18, 2026 | neutral | 0 | 0.6 |
| Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Simply Wall Street | Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Consensus Forecasts Have Become A Little Darker Since Its Latest Report Simply Wall Street | View source ↗ | Simply Wall Street | Aug 13, 2026 | neutral | 0 | 0.6 |
| Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance | Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue Estimates Yahoo Finance | View source ↗ | Yahoo Finance | Aug 10, 2026 | neutral | 0 | 0.6 |
| Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside - TradingView | Orchestra BioMed Holdings, Inc. Stock 12‑Month Price Target Raised to $12.33, Implies 177% Upside TradingView | View source ↗ | TradingView | Aug 10, 2026 | neutral | 0 | 0.6 |
| Orchestra BioMed: Nearing The First Of Two Pivotal Readouts (NASDAQ:OBIO) - Seeking Alpha | Orchestra BioMed: Nearing The First Of Two Pivotal Readouts (NASDAQ:OBIO) Seeking Alpha | View source ↗ | Seeking Alpha | Jul 22, 2026 | neutral | 0 | 0.6 |
| OBIO Forecast — Price Target — Prediction for 2027 - TradingView | OBIO Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.